Raines William F III 4

What Happened

• Director William F. Raines III received a grant of 1,572 restricted stock units (RSUs) from cbdMD (YCBD) on April 14, 2026. The RSUs were reported at $0.00 at grant (i.e., no cash paid by the insider) and thus show $0 value at issuance on the Form 4. This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-14; Form 4 filed: 2026-04-16 (timely filing).
• Grant details: 1,572 RSUs at $0.00 (footnote F1).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: Each RSU represents the contingent right to one share. The grant was exempt from Section 16(b) under Rule 16b-3 because it was pre-approved by the issuer’s Compensation, Corporate Governance and Nominating Committee (three non-employee directors). RSUs were issued under the 2021 or 2025 Equity Compensation Plan as director compensation.

Context

• RSUs are not immediately tradable shares; they convert to common stock only upon vesting. These RSUs vest quarterly on June 30, 2026; Sept 30, 2026; Dec 31, 2026; and Mar 31, 2027. Because this is a standard compensation grant approved under company plans, it is routine director pay rather than a directional insider buy or sell signal.